Injectables

Profhilo vs Dermal Filler: Understanding the Difference

A clinical comparison of Profhilo bio-remodelling and dermal filler at The London Road Clinic: what each treats, how they work differently, and how to decide between them. Written by Dr Shahe Boghossian, Medical Consultant, GMC 5204600.

Published 21 May 2026


Following an in-person consultation with our prescribing clinician, in line with current GMC, NMC, GPhC and GDC guidance.

Profhilo and dermal filler are both injectable hyaluronic acid treatments, but they address different aspects of facial ageing and are not alternatives to the same problem. Profhilo improves skin quality: hydration, firmness and collagen stimulation. Dermal filler restores or enhances volume and structure. For many patients, both are relevant at different points in their treatment plan, or simultaneously.


Why this comparison matters

The most common misconception patients bring to a consultation is that Profhilo and dermal filler are competing options for the same concern, and that choosing one means ruling out the other. This framing leads to suboptimal decisions: patients who need structure from filler choosing Profhilo because it sounds more natural; patients who need skin quality improvement choosing filler because it sounds more decisive.

The clinically accurate framing is that these two treatments address different aspects of how the face changes over time, and that understanding both helps patients make more informed decisions, whether that means choosing one, the other, or both.

Facial ageing happens through two broad mechanisms that proceed simultaneously. The skin thins, loses hydration and collagen, and becomes less firm and luminous. Separately, the structural scaffold of the face, the fat compartments, ligaments and bone that give the face its shape, changes in ways that produce volume loss, hollowing and shifting of facial features. These two processes are related but distinct. Treating skin quality does not restore structure; restoring structure does not improve skin quality. Profhilo addresses the first; filler addresses the second.


What each treatment is

Profhilo is a bio-remodeller manufactured by IBSA Pharmaceuticals. It contains 64mg of hyaluronic acid per 2ml syringe, un-cross-linked, produced without the chemical stabilisers found in conventional fillers. Once injected, it spreads through the deeper skin layers, binds water in the tissue, and stimulates fibroblasts to produce collagen, elastin and the skin’s own hyaluronic acid. It does not add volume. It improves the biological quality of the skin over approximately 60 days following a two-session course.

Dermal filler is a cross-linked hyaluronic acid gel placed precisely in a target area to add volume, restore contour, or reduce the appearance of deep folds and shadows. The cross-linking process gives it structural integrity: it stays where it is placed, maintaining its shape in the tissue. Different formulations offer different densities for different anatomical locations, from fine product placed at the lip border to denser product used to restore cheekbone projection.

Both are injectable hyaluronic acid. Beyond that shared ingredient, they are different products with different structures, mechanisms, and purposes.

The full patient guides are at the Profhilo guide and the dermal filler guide.


Head-to-head comparison

Compare Profhilo Dermal Filler
Primary purpose Improve skin quality: hydration, firmness, collagen stimulation, luminosityRestore or enhance volume and structure: cheeks, lips, jaw, folds, hollows
Hyaluronic acid type Un-cross-linked, high concentration (64mg/2ml); spreads through tissueCross-linked gel; remains where placed; varies in density by formulation
Mechanism Spreads through dermis; stimulates fibroblasts to produce collagen, elastin and HA; binds water at dermal levelPhysical volume addition; structural support; can also stimulate collagen over time (product-dependent)
Volume effect None, does not add volume in any defined areaDirect, adds measurable volume at the injection site
Visible immediately No, result builds over 4–10 weeks as biological response developsPartially, some volume visible immediately; final result at 2–4 weeks once swelling settles
Sessions (first course) 2 sessions, 4 weeks apart; maintenance every 6–12 monthsVariable by area and degree of correction; typically 1–2 sessions; maintenance 12–18 months
Duration of result Approximately 6 months; biological collagen stimulation is real but injected HA metabolisesApproximately 12–18 months depending on area, product and metabolism
Reversibility Not cross-linked; metabolises naturally; cannot be dissolved with hyaluronidaseCross-linked HA filler can be dissolved with hyaluronidase if needed
Treatment areas Face, neck, décolletage, handsCheeks, lips, jaw, chin, tear trough, nasolabial folds, temples, hands (area-dependent)
Best suited to Patients noticing skin quality decline: reduced firmness, hydration, luminosity; mild laxity without structural changePatients with volume loss, hollowing, contour change, deep folds, or lip definition loss
Can they be combined? Yes, commonly used together; address different aspects of ageing simultaneouslyYes, filler adds structure; Profhilo improves the skin over the structure

Choose Profhilo if

Your primary concern is skin quality rather than facial structure. Specifically:

  • Your skin has become thinner, drier, less firm or less luminous, but the shape and proportions of your face remain broadly as they were.
  • You are noticing mild laxity in the lower face or jaw line that is driven by skin quality decline rather than significant structural change.
  • You want to improve skin quality in the neck, décolletage or hands, where Profhilo has established clinical data.
  • You want a treatment that works with your skin’s biology rather than altering facial contour.
  • You are in your late 30s or 40s and beginning to notice quality decline but have not yet reached the point where structural volume loss is prominent.

Profhilo is not the right choice if what you are looking at in the mirror is hollowed cheeks, flattened cheekbones, deepened nasolabial folds, or lip thinning. These are structural changes; bio-remodelling will not address them.

Choose dermal filler if

Your primary concern is structural change: volume loss, hollowing, contour or proportion that has changed visibly.

  • Cheeks that have become flat or hollowed, losing their anterior projection.
  • Nasolabial folds (nose-to-mouth lines) that have deepened as the facial fat above them has descended.
  • Lip thinning, loss of lip border definition, or asymmetry.
  • A jaw line that has become less defined due to volume shift and soft tissue descent.
  • Tear trough hollowing producing a shadow or dark circle beneath the eye.
  • Temples that have become hollow.

Filler is not the right choice if the face retains its structural shape but the skin over it has become poor quality. Adding volume to a face with good structure but tired, thin skin may make the structure more visible but will not improve the skin’s quality, hydration or luminosity. Both problems may exist simultaneously; they require different solutions.


Why many patients need both

Facial ageing is simultaneous: skin quality declines at the same time as structure changes, and the two processes reinforce each other visually. A face with significant volume loss covered by poor quality skin looks more aged than either factor alone would suggest. Addressing both produces a more comprehensive result than either alone.

A common treatment sequence at The London Road Clinic for patients in their mid-40s with both concerns: Profhilo first, to improve skin quality and see the face at its current structural best; then a filler assessment once the Profhilo result has developed, to determine what structural correction adds further value. This sequence is not universal; some patients need filler urgently first; others may never need it. The appropriate order is determined at consultation.

The question “Profhilo or filler?” is often less useful than “what does my face need most at this point, and what is the right sequence?”


How they relate to other treatments

Profhilo sits within the regenerative injectable category alongside polynucleotides. The Profhilo vs polynucleotides comparison and the regenerative treatments comparison cover how these relate to each other.

Dermal filler, like all injectable treatments, requires an in-person consultation at The London Road Clinic. The dermal filler patient guide covers product types, areas, risks and the full treatment detail. The role of structural change in facial ageing is covered in the facial volume loss guide. Understanding why collagen and hyaluronic acid decline with age helps contextualise both treatment approaches.

Read more about what to expect at a consultation at The London Road Clinic.


Related advice

Ready to discuss your options?

Book a consultation at The London Road Clinic, Newark. Doctor-led, independently governed, with no obligation to proceed.

Following an in-person consultation with our prescribing clinician, in line with current GMC, NMC, GPhC and GDC guidance.

Registered with & recognised by

Book a consultation WhatsApp